Analysis of the Serum Bile Acid Composition for Differential Diagnosis in Patients with Liver Disease

Table 5

(a) The percentage of patients whose biochemical data exceed 97.5% cut-off value of healthy control. (b) The percentage of patients whose serum concentration of bile acid exceeds 97.5% cut-off value of healthy control.

(a)

(%)	Viral hepatitis; (HBV + HCV)	ALD	Biliary tract disease	NAFLD	Other liver diseases
ALT	53.7	38.1	70.0	46.2	37.9
AST	52.2	61.9	55.0	23.1	44.8
ALP	43.3	57.1	70.0	30.8	55.2
Γ-GTP	34.3	81.0	90.0	15.4	51.7
T-Bil	46.3	47.6	80.0	61.5	48.3
D-Bil	44.8	55.0	78.9	50.0	33.3
TBA	57.6	52.4	52.6	16.7	42.9
ALB	55.2	42.9	20.0	84.6	42.9
PT	42.9	41.5	57.1	57.9	61.5

(b)

(%)	Viral hepatitis; (HBV + HCV)	ALD	Biliary tract disease	NAFLD	Other liver diseases
	67	21	20	13	29
CA	53.7	61.9	35.0	46.2	44.8
GCA	44.8	71.4	60.0	23.1	51.7
TCA	46.3	61.9	65.0	23.1	51.7
CDCA	58.2	71.4	20.0	53.8	34.5
GCDCA	52.2	61.9	60.0	23.1	41.4
TCDCA	50.7	57.1	60.0	23.1	48.3
DCA	56.7	38.1	25.0	84.6	44.8
GDCA	53.7	42.9	60.0	53.8	37.9
TDCA	55.2	42.9	65.0	30.8	41.4
LCA	64.2	38.1	40.0	53.8	31.0
GLCA	62.7	28.6	35.0	53.8	44.8
TLCA	55.2	42.9	65.0	38.5	37.9
UDCA	61.2	66.7	25.0	23.1	41.4
GUDCA	61.2	61.9	25.0	23.1	44.8
TUDCA	59.7	57.1	25.0	23.1	51.7
12-KLCA	62.7	42.9	25.0	61.5	37.9